VitaNova Life Sciences VNOV

OTC VNOV
$2.50 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

VitaNova Life Sciences (VNOV) stock price is $2.50, unchanged on the day, as of Oct 14, 2026. It has a market cap of $33.77Mn, and is classified in the Consulting industry (Industrials sector).

Key Stats
Market Cap33.77 Mn
P/E-295.93
P/S10.41
Div. Yield0.00
Revenue Growth (1y) (Qtr)209.51
Add ratio to table…

About

Yijia Group Corp provides business consulting services and markets anti aging healthcare products designed to boost NAD+ levels. The company commenced operations offering consulting to domestic and international clients regarding funding and other financial matters. It also sells anti aging supplements that promote anti aging, enhance energy metabolism, improve cognitive function, and strengthen cellular repair capabilities. In addition, Yijia Group Corp delivers…

Read more ↓
Sectors: Industrials Consumer Staples Sector rationale The company's primary segment is the Consulting Service Segment, providing management, accounting, and finance advisory services to corporate clients, which falls under the Consulting industry within Industrials. The Healthcare Segment sells anti-aging supplements and nutrition plans to individual consumers; since these are health-related supplements/wellness products sold to consumers, they are classified under Consumer Staples (Personal Care Products/Household Products). Industries: Consulting Consulting Primary The company operates a Consulting Service Segment that provides advisory services in management business, accounting, and finance, specifically assisting clients with funding and financial management. Personal Care Products Personal Care Products Secondary The company's Healthcare Segment sells anti-aging supplements designed to boost NAD+ levels, enhance energy metabolism, and improve cognitive function, which fall under over-the-counter consumer health and wellness products. Classified using BQ-MICS CIK: 0001699709

Timing of Transfer of Good or Service Breakdown of Revenue (2026)

History

Segments Breakdown of Revenue (2026)

History
Peer percentiles

How VitaNova Life Sciences ranks

Ranked against the 130 companies in Business Services58 metrics · as of Oct 16, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −183xMedian 19.9x 39th
  • P/FCF 37.4xMedian 11.8x 48th
  • P/Operating cash flow 37.4xMedian 10.2x 29th
  • P/S 6.43xMedian 0.82x 11th
  • P/B 10.8xMedian 2.17x 11th
  • P/Tangible book 10.8xMedian 2.90x 14th
  • EV/EBITDA —Median 11.7x No data —
  • EV/EBITNegative EBIT −223xMedian 16.5x 32nd
  • EV/Revenue 5.93xMedian 1.11x 10th
  • EV/FCF 34.5xMedian 16.8x 44th
  • EV/Operating cash flow 34.5xMedian 14.2x 29th
  • PEG (3Y EPS CAGR)Negative earnings 11.0Median 0.98 Not meaningful —
Peer group

Peer Comparison

Companies in the Consulting
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 ACN Accenture plc 146.43 Bn18.802.005.14 Bn
2 CTAS Cintas Corp 86.79 Bn42.127.512.43 Bn
3 IRM Iron Mountain Inc 33.63 Bn80.334.4517.35 Bn
4 APG APi Group Corp 17.31 Bn-69.812.053.52 Bn
5 ROL Rollins Inc 16.03 Bn30.144.080.70 Bn
6 ULS UL Solutions Inc. 14.80 Bn29.304.700.30 Bn
7 ARMK Aramark 14.78 Bn38.600.746.13 Bn
8 VNOV VitaNova Life Sciences Corp 0.03 Bn-295.9310.41-